Niraparib as maintenance for platinum-sensitive ovarian cancer - results from ENGOT-OV16/NOVA trial
The role of nicotine in cancer and its impact on therapy
Side effects of chemotherapy vs. immunotherapy
Andrea B. Apolo
Tremelimumab and durvalumab therapy in lung cancer
Pembrolizumab or EGFR tyrosine kinase inhibitors in NSCLC?